Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Akorn Inc (AKRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 4,129,855
  • Shares Outstanding, K 124,920
  • Annual Sales, $ 1,117 M
  • Annual Income, $ 184,240 K
  • 36-Month Beta 1.38
  • Price/Sales 3.71
  • Price/Cash Flow 11.15
  • Price/Book 4.67

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.30 +2.35%
on 08/23/17
33.46 -1.20%
on 09/12/17
+0.54 (+1.66%)
since 08/22/17
3-Month
31.82 +3.90%
on 08/18/17
33.73 -1.99%
on 07/17/17
-0.47 (-1.40%)
since 06/22/17
52-Week
17.61 +87.73%
on 12/07/16
34.00 -2.76%
on 04/24/17
+5.18 (+18.58%)
since 09/22/16

Most Recent Stories

More News
Sucampo Pha-Cl A has the Best Relative Performance in the Pharmaceuticals Industry (SCMP, AKRX, SUPN, ZTS, MRK)

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

SCMP : 11.80 (-0.42%)
SUPN : 39.00 (-1.02%)
MRK : 65.13 (-0.72%)
ZTS : 64.16 (-0.12%)
AKRX : 33.06 (-0.24%)
Akorn Inc Up 50.3% Since SmarTrend Uptrend Call (AKRX)

SmarTrend identified an Uptrend for Akorn Inc (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 6 months, Akorn Inc has returned 50.28% as of today's recent price of $32.58.

AKRX : 33.06 (-0.24%)
Akorn Inc Has Returned 53.9% Since SmarTrend Recommendation (AKRX)

SmarTrend identified an Uptrend for Akorn Inc (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 6 months, Akorn Inc has returned 53.87% as of today's recent price of $33.36.

AKRX : 33.06 (-0.24%)
Shares of AKRX Up 54.3% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Akorn Inc (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 6 months, Akorn Inc has returned 54.29% as of today's recent price of $33.45.

AKRX : 33.06 (-0.24%)
Akorn Inc Up 55.0% Since SmarTrend Uptrend Call (AKRX)

SmarTrend identified an Uptrend for Akorn Inc (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 5 months, Akorn Inc has returned 54.98% as of today's recent price of $33.60.

AKRX : 33.06 (-0.24%)
Akorn Inc Has Returned 55.2% Since SmarTrend Recommendation (AKRX)

SmarTrend identified an Uptrend for Akorn Inc (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 5 months, Akorn Inc has returned 55.17% as of today's recent price of $33.64.

AKRX : 33.06 (-0.24%)
Shares of AKRX Up 54.9% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Akorn Inc (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 5 months, Akorn Inc has returned 54.87% as of today's recent price of $33.58.

AKRX : 33.06 (-0.24%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: August 21, 2017

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed on behalf of common stock shareholders of Akorn, Inc. ("Akorn" or the "Company")...

AKRX : 33.06 (-0.24%)
Generic Drugs Stocks on Investors' Radar -- Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharma

If you want a Stock Review on AKRX, COLL, MNTA or DPLO then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Tuesday, June 27, 2017, US markets...

COLL : 10.31 (+2.49%)
MNTA : 17.15 (+2.08%)
AKRX : 33.06 (-0.24%)
DPLO : 20.75 (-0.05%)
Shares of AKRX Up 54.9% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Akorn Inc (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 4 months, Akorn Inc has returned 54.89% as of today's recent price of $33.58.

AKRX : 33.06 (-0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products. Customers include physicians, optometrists, wholesalers,...

See More

Support & Resistance

2nd Resistance Point 33.20
1st Resistance Point 33.13
Last Price 33.06
1st Support Level 33.01
2nd Support Level 32.96

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.